Sort
326,823 grants matching “clinical trial”
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
$1,986,024Mark Cookson · National Institute On Aging · ZIA · FY2020 · AG
Investigating Correlates and Therapeutics of Fatigue
$1,985,985Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2025 · NR
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
$1,985,974Elisabeth J Cohen · New York University School Of Medicine · U10 · FY2020 · EY
CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS) - HIV/AIDS
$1,985,928Melynda Holmes · Technical Resources International, Inc. · N01 · FY2023 · AI
The Synergy Between Radiotherapy and Molecularly Targeted Agents
$1,985,894Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing
$1,985,831Kellie Bickel · Twinstrand Biosciences, Inc. · R44 · FY2025 · CA
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$1,985,586Stephen A Spector · University Of California, San Diego · UM1 · FY2024 · AI
Pathophysiology and Treatment of Fanconi Anemia
$1,985,543Markus Grompe · Oregon Health & Science University · P01 · FY2018 · HL
Mixed Hematopoietic Chimerism after Stem Cell Allografts
$1,985,492Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Preclinical Toxicology & Pharmacology of Drugs Developed for Cancer
$1,985,380James E. Estep · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2010 · CA
Flavivirus Infections: Pathogenesis and Prevention
$1,985,380Alan L Rothman · University Of Rhode Island · P01 · FY2012 · AI
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
$1,985,332Sandy Feng · University Of California, San Francisco · U01 · FY2012 · AI
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy
$1,985,262Daniel Fowler · Clinical Sciences · Z01 · FY2007 · CA
Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration
$1,985,236Valter D. Longo · University Of Southern California · P01 · FY2022 · AG
NK Cells, Their Receptors and Unrelated Donor Transplant
$1,985,078Jeffrey S Miller · University Of Minnesota · P01 · FY2006 · CA
AAV Gene Therapy for Lipid Disorders
$1,985,074James M Wilson · University Of Pennsylvania · P01 · FY2016 · HL
Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage
$1,985,040Jonathan Rosand · Massachusetts General Hospital · R01 · FY2024 · NS
Community Clinical Oncology program Research Base
$1,984,870Brad H. Pollock · National Childhood Cancer Foundation · U10 · FY2008 · CA
RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD
$1,984,868Scott T Weiss · Brigham And Women'S Hospital · R01 · FY2015 · HL
Data Coordination Center for STEADY-PD3
$1,984,635Robert G. Holloway · University Of Rochester · U01 · FY2017 · NS
First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
$1,984,624Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2021 · AG
IGF::OT::IGF R&D- NANOEMULSION FORMULATION AND IND-ENABLING STUDIES OF A NOVEL CENTER STEM CELL CYTOTOXIC AGENT
$1,984,617James Egan · Targagenix, Inc. · N44 · FY2016 · CA
fMRI Studies Of Pediatric Mood And Anxiety Disorders
$1,984,584Daniel Pine · National Institute Of Mental Health · ZIA · FY2016 · MH
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
$1,984,538George Drusano · Ordway Research Institute, Inc. · N01 · FY2010 · AI
Alzheimer Disease Research Center
$1,984,522Helena Chang Chui · University Of Southern California · P50 · FY2013 · AG